Ignite Creation Date:
2025-12-24 @ 7:33 PM
Ignite Modification Date:
2025-12-25 @ 5:15 PM
Study NCT ID:
NCT00378703
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2006-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-21
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-19
First Submit QC Date:
None
Study First Post Date:
2006-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-14
Results First Submit QC Date:
None
Results First Post Date:
2015-05-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-15
Last Update Post Date:
2018-11-14
Last Update Post Date Type:
ACTUAL